Filter by: patients
Home > Community Treatment Reports and Side Effects > Gammaglobulin (IVIg) Treatment Report
What is Gammaglobulin (IVIg)?

Intravenous gammaglobulin, or immune globulin (IVIg) has been used in the treatment of various autoimmune diseases and in relapsing-remitting MS. Studies report a reduction in the number and severity of acute exacerbations and resulted in a lesser neurological disability.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
MS (Multiple Sclerosis) 8 2 Efficacy_moderate Efficacy_cant_tell
Guillain–Barré syndrome 4 1 Efficacy_major
Relapse MS (exacerbation) 2 1 Efficacy_slight
Exhaustion 1 1 Efficacy_major
Support immune health 1 0
General health 1 0

See all 13 patients currently taking Gammaglobulin (IVIg)

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 1
Mild
 2
None
 4

Commonly reported side effects, conditions, and hospitalizations associated with Gammaglobulin (IVIg)

Pain in lower back 1
Unintentional weight loss 1
Chills during infusion 1

Reported Dosages

Frequently reported dosages based on patients currently taking Gammaglobulin (IVIg). See all 13 dosages ►

  1 other every other week 15 g monthly 35 g monthly 40 mg monthly 45 g monthly 30 g every other week 68 mg monthly 3 other daily 200 mg monthly 40 L daily
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Gammaglobulin (IVIg) (multiple reasons could be selected)
Reason # Patients Percentage of patients
Course of treatment ended 10   Course of treatment ended: 77%
Did not seem to work 2   Did not seem to work: 15%
Doctor's advice 2   Doctor's advice: 15%
Change in health plan coverage 1   Change in health plan coverage: 8%

See all 13 patients who’ve stopped taking Gammaglobulin (IVIg)

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Gammaglobulin (IVIg)

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Stopped Taking Gammaglobulin (IVIg)

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Gammaglobulin (IVIg)

Always
 5 71%
Usually
 0 0%
Sometimes
 0 0%
Never
 2 29%

Burden

Difficulty being on treatment

Burden of Gammaglobulin (IVIg)

Very
 0 0%
Somewhat
 2 29%
A little
 1 14%
Not at all
 4 57%

Cost

Paid out of pocket

Cost of Gammaglobulin (IVIg)

$200+
 1 25%
$100-199
 0 0%
$50-99
 0 0%
$25-49
 0 0%
< $25
 3 75%

Report created on May 24, 2012.